Hospira to Present at the Morgan Stanley Global Healthcare Conference
LAKE FOREST, Ill., Aug. 15, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the Morgan Stanley Global Healthcare Conference on Tuesday, Sept. 9, 2014, in New York.
The presentation is scheduled to begin at 11:45 a.m. Eastern time on Tuesday, Sept. 9, 2014. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. Any accompanying slides will be available on the Hospira website. A replay of the webcast will be available on the Hospira website approximately 24 hours after the live presentation for 30 days after the event.
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 17,000 employees. Learn more at www.hospira.com.
SOURCE Hospira, Inc.